U.S., March 18 -- ClinicalTrials.gov registry received information related to the study (NCT06878495) titled 'Efficacy and Safety of Discontinuing 5-ASA in Patients with Inflammatory Bowel Disease' on Feb. 02.
Brief Summary: This study aims to evaluate the long-term outcomes of discontinuing 5-ASA in UC and CD patients receiving stable biologic or immunomodulator therapy using a prospective cohort based in the Busan-Ulsan-Gyeongnam region. It seeks to determine whether discontinuing 5-ASA is a safe treatment strategy in modern IBD management.
Study Start Date: April 01
Study Type: INTERVENTIONAL
Condition:
Ulcerative Colitis (UC)
Crohn's Disease
Inflammatory Bowel Disease (IBD)
Intervention:
OTHER: Discontinuation of 5-ASA
Disco...